Callan Family Office LLC Takes $300,000 Position in Molina Healthcare, Inc $MOH

Callan Family Office LLC purchased a new stake in Molina Healthcare, Inc (NYSE:MOH) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,008 shares of the company’s stock, valued at approximately $300,000.

Other large investors have also recently modified their holdings of the company. Teacher Retirement System of Texas purchased a new stake in Molina Healthcare during the first quarter worth $2,759,000. Farther Finance Advisors LLC lifted its holdings in Molina Healthcare by 100.3% during the first quarter. Farther Finance Advisors LLC now owns 659 shares of the company’s stock worth $216,000 after buying an additional 330 shares during the period. Swedbank AB lifted its holdings in Molina Healthcare by 6.8% during the second quarter. Swedbank AB now owns 102,176 shares of the company’s stock worth $30,438,000 after buying an additional 6,484 shares during the period. Acadian Asset Management LLC lifted its holdings in Molina Healthcare by 3,192.6% during the first quarter. Acadian Asset Management LLC now owns 5,762 shares of the company’s stock worth $1,897,000 after buying an additional 5,587 shares during the period. Finally, Robeco Institutional Asset Management B.V. purchased a new stake in Molina Healthcare during the first quarter worth $1,070,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Transactions at Molina Healthcare

In related news, COO James Woys purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 4th. The shares were purchased at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the purchase, the chief operating officer owned 74,331 shares of the company’s stock, valued at $11,591,176.14. This represents a 15.54% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronna Romney sold 700 shares of the firm’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Molina Healthcare Trading Down 2.1%

MOH stock opened at $188.26 on Friday. The company’s 50-day simple moving average is $181.22 and its 200-day simple moving average is $245.68. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $359.97. The firm has a market cap of $10.20 billion, a P/E ratio of 9.28 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts’ consensus estimates of $5.50 by ($0.02). The company had revenue of $11.43 billion during the quarter, compared to analysts’ expectations of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the business posted $5.86 earnings per share. As a group, equities analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Analysts Set New Price Targets

MOH has been the topic of a number of recent analyst reports. Sanford C. Bernstein reduced their price target on Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a research report on Friday, September 5th. UBS Group reduced their price target on Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating on the stock in a research report on Friday, July 25th. Barclays reduced their price target on Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 4th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a research report on Wednesday, October 8th. Finally, The Goldman Sachs Group initiated coverage on Molina Healthcare in a research report on Tuesday. They set a “neutral” rating and a $207.00 price target on the stock. Three research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $222.15.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.